The chimeric antibody PPAT-057-17C was found to have strong reactivity with a CDH3-expressing cell line. The antitumor effects of the chimeric antibody PPAT-057-17C were confirmed using xenograft models, into which a human lung cancer-derived cell line NCI-H358 had been transplanted.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0615 | Hi-Affi™ Rabbit Anti-CDH15 Recombinant Antibody (clone DS615AB) | WB | Rabbit IgG |
There are currently no Customer reviews or questions for HPAB-0224-CN-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.